Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

COPD device approved on NHS drug tariff

  • Comment

A device for treating chronic obstructive pulmonary disease, cystic fibrosis and bronchiectasis has received approval for inclusion in the NHS drug tariff approval, meaning it can be prescribed by clinicians with immediate effect.

Nebusal (sterile 7 per cent hypertonic sodium chloride solution) increases the mobilisation of secretions in the lower respiratory tract for patients with persistent mucus by a process of osmosis.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs